Search

Xencor Inc

Gesloten

SectorGezondheidszorg

26.58 0.57

Overzicht

Wijziging aandelenprijs

24u

Huidig

Min

26.58

Max

26.73

Belangrijke statistieken

By Trading Economics

Inkomsten

107M

-22M

Verkoop

47M

51M

EPS

-0.29

Winstmarge

-42.422

Werknemers

260

EBITDA

109M

-12M

Aanbevelingen

By TipRanks

Aanbevelingen

Strong Buy

12 Maanden Prognose

+16.5% upside

Dividenden

By Acuity

Volgende Winsten

3 nov 2026

Marktinformatie

By TradingEconomics

Marktkapitalisatie

589M

2B

Vorige openingsprijs

26.01

Vorige sluitingsprijs

26.58

Nieuwssentiment

By Acuity

50%

50%

131 / 339 Rangschikking in Healthcare

Xencor Inc Grafiek

Eerdere prestaties zijn geen betrouwbare indicator voor toekomstige resultaten.

Gerelateerd nieuws

4 sep 2026, 20:07 UTC

Xencor Inc shares are higher, recovering from earlier losses amid broader market selling pressure following a strong jobs report. No specific news was identified.

3 sep 2026, 22:15 UTC

News

Shares lower in after-market trading after JP Morgan's rating.

2 sep 2026, 20:08 UTC

Xencor Inc shares are lower today, reversing from an early gain amid a weaker-than-expected ADP employment report affecting investor sentiment on interest rates.

1 sep 2026, 23:01 UTC

Xencor Inc shares are lower in after-market hours, with no specific news identified. This decline occurs amid broader market concerns over economic growth data.

31 aug 2026, 20:03 UTC

Xencor Inc shares are higher today, supported by strong trading volume. The stock is above its 20-day moving average and near its one-month range high.

28 aug 2026, 20:02 UTC

Xencor Inc shares are lower today, breaking a trend of higher closes. The decline occurs amid rising U.S. Treasury yields and high trading volume.

27 aug 2026, 20:07 UTC

Xencor Inc shares are higher today, recovering from an early dip. The stock is trading well above its 20-day moving average.

26 aug 2026, 23:01 UTC

Xencor Inc shares are lower in after-market trading amid overall market declines. No specific news was identified to explain the stock's movement.

25 aug 2026, 19:36 UTC

Xencor Inc shares are higher, supported by declining crude oil prices and lower Treasury yields. The stock remains above its 20-day moving average.

24 aug 2026, 19:46 UTC

Xencor Inc's shares are higher Monday, rebounding from an earlier low amid rising oil prices and geopolitical tensions, despite no specific company news.

21 aug 2026, 21:41 UTC

Xencor Inc shares are higher in after-market trading, following a recent trend that shows a 44% increase over the past month.

20 aug 2026, 19:56 UTC

Correlated Moves

Xencor Inc shares declined during Thursday's session amid broader sector weakness, influenced by negative sentiment following Walmart's disappointing earnings report.

19 aug 2026, 20:03 UTC

Xencor Inc shares are higher during Wednesday's session, driven by strong market performance and high trading volume. No specific news was identified to explain the move.

18 aug 2026, 20:03 UTC

Xencor Inc shares are trading higher today, supported by strong upward momentum and unusually high market volume. No specific news was identified for the movement.

17 aug 2026, 19:26 UTC

Social Media

Xencor Inc shares are lower despite increased institutional interest, including Johnson & Johnson's $12 million acquisition of 748,062 shares.

14 aug 2026, 19:16 UTC

Shares of Xencor Inc. are modestly higher amid cautious broader market sentiment following a decline in U.S. retail sales for July.

13 aug 2026, 19:21 UTC

Xencor Inc shares are lower today, with no specific news driving the decline. High trading volume suggests increased activity amid routine fluctuations.

12 aug 2026, 19:56 UTC

Social Media

Xencor Inc shares are higher, supported by social media discussions valuing the company at $1.3 billion based on its ENPP3 asset potential.

11 aug 2026, 19:26 UTC

Xencor Inc shares are advancing, continuing a four-session trend. Investors are focused on upcoming inflation reports that may influence market sentiment.

10 aug 2026, 19:31 UTC

News

Xencor Inc shares are higher today, buoyed by increased institutional investments from Dimensional Fund Advisors and BVF Inc. IL.

7 aug 2026, 23:16 UTC

Xencor Inc shares are higher in after-market trading, supported by decreased interest rate hike expectations following a Labor Department report on non-farm payrolls.

6 aug 2026, 20:03 UTC

News

Xencor shares are higher as Cantor Fitzgerald raises its price target to $44, reflecting confidence in the company's pipeline and upcoming ESMO Congress presentation.

3 aug 2026, 19:51 UTC

Xencor Inc's shares are declining, continuing a downward trend since Friday's close, despite a broader market rally in technology and airlines.

31 jul 2026, 20:03 UTC

Xencor Inc shares are lower, reversing earlier gains amid rising US Treasury yields and crude oil prices, contributing to inflation concerns and interest rate expectations.

30 jul 2026, 19:03 UTC

News
Social Media

Xencor Inc. gains following a $105 million settlement with Alexion, boosting investor confidence and extending its operating runway through 2028.

29 jul 2026, 19:36 UTC

Xencor Inc. shares are lower as broader market trends decline ahead of the Federal Reserve's policy announcement, amid rising oil prices and inflation concerns.

28 jul 2026, 20:07 UTC

Xencor Inc is gaining amid a strong Biotechnology sector, despite earlier declines. The stock has rebounded to settle near the upper end of its one-month range.

27 jul 2026, 19:11 UTC

Xencor Inc shares are higher today, reflecting a positive market environment despite earlier intraday pullbacks. No specific news was identified to explain the movement.

24 jul 2026, 19:11 UTC

Xencor Inc shares are lower in Friday's session, reflecting broader market trends. No specific news was identified to explain the price movement.

22 jul 2026, 20:06 UTC

Xencor Inc shares are lower today, retracing from an earlier peak. Broader market sentiment is affected by uncertainty ahead of the Federal Reserve meeting.

Peer Vergelijking

Prijswijziging

Xencor Inc Prognose

Koersdoel

By TipRanks

16.5% opwaarts potentieel

12 Maanden Prognose

Gemiddelde 31 USD  16.5%

Hoogste 46 USD

Laagste 20 USD

Gebaseerd op 12 Wall Street-analisten die 12-maands prijsdoelen bieden voor Xencor Inc - Dist. in de afgelopen 3 maanden.

Beoordelingsconsensus

By TipRanks

Strong Buy

12 ratings

10

Buy

2

Hold

0

Sell

Sentiment

By Acuity

131 / 339 Rangschikking in Gezondheidszorg

Nieuwssentiment

Neutral

Volatiliteit

Onder gemiddelde

Nieuws Volume (RCV)

Gemiddelde

Financieel

Verkoop- en administratiekosten

Bedrijfskosten

Winst voor belastingen

Verkoop

Kosten van verkopen

Brutowinst op verkopen

Rente-uitgaven op schulden

EBITDA

Operationele winst

$

Over Xencor Inc

Xencor, Inc. is a clinical-stage biopharmaceutical company that is focused on discovering and developing engineered monoclonal antibody and cytokine therapeutics to treat patients with cancer and autoimmune diseases. The Company uses its engineering capabilities to enable its understanding of protein structure and interactions to design XmAb technologies and develop candidates with properties. Its antibody design is focused on the segment of antibodies that interact with target antigens. It is focused on the Fc domain, which is the part of an antibody that interacts with various segments of the immune system and controls antibody structure. The Fc domain is constant and interchangeable among antibodies, and its engineered Fc domains are the XmAb technology, which can be readily substituted for natural Fc domains. Its drug candidates include Plamotamab, XmAb717, Vibecotamab, Tidutamab, XmAb841, XmAb104, XmAb306, XmAb104, XmAb564 and XmAb698.
help-icon Live chat